Altuglas International has introduced Altuglas Luctor polymethyl methacrylate (PMMA) alloy that flows twice far as conventional transparent medical polymers in thin wall injection mold cavities. With this new material, devices such as intravenous (IV) line components can be molded with thinner wall sections, using multi-cavity molds to reduce material and processing costs. Altuglas Luctor PMMA is free of bisphenol A (BPA).
Healthcare cost management initiatives and competition among device companies are placing greater demand on medical component manufacturers to reduce costs. Material costs can be reduced by designing components with thinner wall sections. Processing costs can be reduced by decreasing sprue and runner sizes and increasing the number of cavities in multi-cavity molds. These savings can only be achieved with materials that offer substantial improvements in melt flow. Altuglas Luctor PMMA alloy is a chemical resistant, transparent polymer that offers a step-wise improvement in flow over traditional transparent polymers, such as PMMA and polycarbonate. This new PMMA alloy flows 33in. (838mm) in injection mold cavities with dimensions of 0.1in. (2.5mm) thick and 0.5in. (12.7mm) wide, more than double that of traditional chemical resistant acrylic and polycarbonate.
For more information, visit www.altuglasint.com .
Altuglas International has introduced Altuglas Luctor polymethyl methacrylate (PMMA) alloy that flows twice far as conventional transparent medical polymers in thin wall injection mold cavities.